• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非霍奇金淋巴瘤中CDw52抗原表达的免疫组织化学分析

Immunohistochemical analysis of CDw52 antigen expression in non-Hodgkin's lymphomas.

作者信息

Salisbury J R, Rapson N T, Codd J D, Rogers M V, Nethersell A B

机构信息

Department of Histopathology, King's College School of Medicine and Dentistry, London.

出版信息

J Clin Pathol. 1994 Apr;47(4):313-7. doi: 10.1136/jcp.47.4.313.

DOI:10.1136/jcp.47.4.313
PMID:8027367
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC501933/
Abstract

AIM

To determine the antigen expression of CDw52 using Campath-1 antibodies in a series of non-Hodgkin's lymphomas (NHLs).

METHODS

Tissue sections of lymphoma were stained immunohistochemically using rat Campath-1G and humanised Campath-1H with avidin-biotin-peroxidase complex techniques. Fifty-two fresh frozen lymphomas and a further 26 paraffin wax embedded sections were studied.

RESULTS

Thirty-seven out of 41 B cell lymphomas were positive with Campath-1H in frozen sections (low grade, 24 of 24; high grade, 13 of 17) as were three out of five T cell lymphomas. Reed-Sternberg cells in six cases of Hodgkin's disease did not react. Eleven out of 16 high grade B cell lymphomas also stained positively with Campath-1G in paraffin wax sections as did five out of 10 T cell lymphomas.

CONCLUSIONS

The Campath-1 antibodies showed that CDw52 antigen expression was present in all cases of low grade B cell NHL examined. Immunohistochemical staining in high grade B cell NHL and in T cell NHL was variable. These findings may be relevant to patient selection when considering treatment with Campath-1 antibodies.

摘要

目的

使用Campath-1抗体确定一系列非霍奇金淋巴瘤(NHL)中CDw52的抗原表达。

方法

采用抗生物素蛋白-生物素-过氧化物酶复合物技术,用大鼠Campath-1G和人源化Campath-1H对淋巴瘤组织切片进行免疫组织化学染色。研究了52例新鲜冰冻淋巴瘤以及另外26例石蜡包埋切片。

结果

41例B细胞淋巴瘤中有37例在冰冻切片中Campath-1H呈阳性(低级别,24例中的24例;高级别,17例中的13例),5例T细胞淋巴瘤中有3例呈阳性。6例霍奇金病中的里德-斯腾伯格细胞无反应。16例高级别B细胞淋巴瘤中有11例在石蜡切片中Campath-1G也呈阳性,10例T细胞淋巴瘤中有5例呈阳性。

结论

Campath-1抗体显示,在所检查的所有低级别B细胞NHL病例中均存在CDw52抗原表达。高级别B细胞NHL和T细胞NHL中的免疫组织化学染色情况不一。这些发现可能与考虑使用Campath-1抗体进行治疗时的患者选择有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58e1/501933/8b15660d4800/jclinpath00217-0034-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58e1/501933/9e7918e09460/jclinpath00217-0032-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58e1/501933/8b15660d4800/jclinpath00217-0034-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58e1/501933/9e7918e09460/jclinpath00217-0032-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58e1/501933/8b15660d4800/jclinpath00217-0034-a.jpg

相似文献

1
Immunohistochemical analysis of CDw52 antigen expression in non-Hodgkin's lymphomas.非霍奇金淋巴瘤中CDw52抗原表达的免疫组织化学分析
J Clin Pathol. 1994 Apr;47(4):313-7. doi: 10.1136/jcp.47.4.313.
2
CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.CD30分布。对甲醛固定、石蜡包埋的霍奇金淋巴瘤和非霍奇金淋巴瘤的免疫组织化学研究。
Arch Pathol Lab Med. 1992 Nov;116(11):1197-201.
3
CAMPATH-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas: a phase II multicenter study. European Study Group of CAMPATH-1H Treatment in Low-Grade Non-Hodgkin's Lymphoma.
J Clin Oncol. 1998 Oct;16(10):3257-63. doi: 10.1200/JCO.1998.16.10.3257.
4
Immunoperoxidase staining of non-Hodgkin's lymphomas for T-cell lineage associated antigens in paraffin sections. Comparison of the performance characteristics of four commercially available antibody preparations.石蜡切片中非霍奇金淋巴瘤T细胞系相关抗原的免疫过氧化物酶染色。四种市售抗体制剂性能特征的比较。
Am J Surg Pathol. 1993 Sep;17(9):898-904. doi: 10.1097/00000478-199309000-00005.
5
Methods in pathology. Identification of T-cell lymphomas in paraffin-embedded tissues using polyclonal anti-CD3 antibody: comparison with frozen section immunophenotyping and genotypic analysis.病理学方法。使用多克隆抗CD3抗体鉴定石蜡包埋组织中的T细胞淋巴瘤:与冰冻切片免疫表型分析和基因分型分析的比较。
Mod Pathol. 1991 May;4(3):358-62.
6
A phase II multicenter study of CAMPATH-1H antibody in previously treated patients with nonbulky non-Hodgkin's lymphoma.
Leuk Lymphoma. 2001 Mar;41(1-2):77-87. doi: 10.3109/10428190109057956.
7
Heterogeneous CD52 expression among hematologic neoplasms: implications for the use of alemtuzumab (CAMPATH-1H).血液系统肿瘤中CD52表达的异质性:对阿仑单抗(CAMPATH-1H)应用的影响。
Clin Cancer Res. 2006 Dec 1;12(23):7174-9. doi: 10.1158/1078-0432.CCR-06-1275.
8
p53, c-myc p62 and proliferating cell nuclear antigen (PCNA) expression in non-Hodgkin's lymphomas.非霍奇金淋巴瘤中p53、c-myc、p62及增殖细胞核抗原(PCNA)的表达
J Clin Pathol. 1994 Jan;47(1):9-14. doi: 10.1136/jcp.47.1.9.
9
Immunophenotypic analysis of extranodal non-Hodgkin's lymphomas in the oral cavity.口腔结外非霍奇金淋巴瘤的免疫表型分析
Pathol Res Pract. 1993 Apr;189(3):300-11. doi: 10.1016/S0344-0338(11)80514-5.
10
Paraffin-resistant antigens detectable by antibodies L26 and polyclonal CD3 predict the B- or T-cell lineage of 95% of diffuse aggressive non-Hodgkin's lymphomas.可被抗体L26和多克隆CD3检测到的抗石蜡抗原可预测95%的弥漫性侵袭性非霍奇金淋巴瘤的B细胞或T细胞谱系。
Am J Clin Pathol. 1994 Sep;102(3):284-91. doi: 10.1093/ajcp/102.3.284.

引用本文的文献

1
Shaping the Future of Behçet's Uveitis Management: A Comprehensive Review of Efficacy, Challenges, and Prospects of Biologic Therapies.塑造白塞氏葡萄膜炎治疗的未来:生物疗法的疗效、挑战与前景综合综述
Ophthalmol Ther. 2023 Oct;12(5):2295-2321. doi: 10.1007/s40123-023-00767-0. Epub 2023 Jul 21.
2
Cutaneous T-cell lymphomas: a review of new discoveries and treatments.皮肤 T 细胞淋巴瘤:新发现和治疗方法综述。
Curr Treat Options Oncol. 2012 Mar;13(1):102-21. doi: 10.1007/s11864-011-0179-8.
3
Dose modification of alemtuzumab in combination with dexamethasone, cytarabine, and cisplatin in patients with relapsed or refractory peripheral T-cell lymphoma: analysis of efficacy and toxicity.

本文引用的文献

1
Structure of the CAMPATH-1 antigen, a glycosylphosphatidylinositol-anchored glycoprotein which is an exceptionally good target for complement lysis.CAMPATH-1抗原的结构,一种糖基磷脂酰肌醇锚定糖蛋白,是补体裂解的极佳靶点。
Biochem J. 1993 Aug 1;293 ( Pt 3)(Pt 3):633-40. doi: 10.1042/bj2930633.
2
The glycosylphosphatidylinositol-anchored lymphocyte antigen CDw52 is associated with the epididymal maturation of human spermatozoa.
J Reprod Immunol. 1993 Mar;23(2):189-205. doi: 10.1016/0165-0378(93)90007-5.
3
Effects of monoclonal anti-lymphocyte antibodies in vivo in monkeys and humans.
Mol Biol Med. 1983 Oct;1(3):321-34.
4
在复发或难治性外周 T 细胞淋巴瘤患者中,联合使用阿仑单抗、地塞米松、阿糖胞苷和顺铂时的剂量调整:疗效和毒性分析。
Invest New Drugs. 2012 Feb;30(1):368-75. doi: 10.1007/s10637-010-9523-2. Epub 2010 Aug 24.
4
Circulating CD52 and CD20 levels at end of treatment predict for progression and survival in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab (FCR).在接受氟达拉滨、环磷酰胺和利妥昔单抗(FCR)治疗的慢性淋巴细胞白血病患者中,治疗结束时循环 CD52 和 CD20 水平可预测疾病进展和生存。
Br J Haematol. 2010 Feb;148(3):386-93. doi: 10.1111/j.1365-2141.2009.07965.x. Epub 2009 Nov 6.
5
131I anti-CD45 radioimmunotherapy effectively targets and treats T-cell non-Hodgkin lymphoma.131I抗CD45放射免疫疗法可有效靶向治疗T细胞非霍奇金淋巴瘤。
Blood. 2009 Jun 4;113(23):5905-10. doi: 10.1182/blood-2009-02-205476. Epub 2009 Mar 30.
6
[Treatment of hematological malignancies with monoclonal antibodies].[单克隆抗体治疗血液系统恶性肿瘤]
Internist (Berl). 2008 Aug;49(8):929-30, 932-4, 936-7. doi: 10.1007/s00108-008-2057-4.
7
Antibody therapy for chronic lymphocytic leukemia.慢性淋巴细胞白血病的抗体疗法。
Semin Hematol. 2008 Apr;45(2):95-103. doi: 10.1053/j.seminhematol.2008.02.001.
8
Richter's syndrome: a novel presentation.里氏综合征:一种新的表现形式。
Ulster Med J. 2003 May;72(1):58-60.
9
Campath-1H (anti-CD52) monoclonal antibody therapy in lymphoproliferative disorders.Campath-1H(抗CD52)单克隆抗体疗法治疗淋巴增殖性疾病。
Med Oncol. 2001;18(2):99-107. doi: 10.1385/mo:18:2:99.
Removal of T cells from bone marrow for transplantation. Comparison of rat monoclonal anti-lymphocyte antibodies of different isotypes.
Mol Biol Med. 1983 Oct;1(3):305-19.
5
Removal of T cells from bone marrow for transplantation: a monoclonal antilymphocyte antibody that fixes human complement.从骨髓中去除T细胞用于移植:一种能固定人补体的单克隆抗淋巴细胞抗体。
Blood. 1983 Oct;62(4):873-82.
6
Two distinct antigen systems in human B lymphocytes: identification of cell surface and intracellular antigens using monoclonal antibodies.人类B淋巴细胞中的两种不同抗原系统:利用单克隆抗体鉴定细胞表面和细胞内抗原
Clin Exp Immunol. 1984 Oct;58(1):183-92.
7
Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.抗生物素蛋白-生物素-过氧化物酶复合物(ABC)在免疫过氧化物酶技术中的应用:ABC法与未标记抗体(PAP)法的比较。
J Histochem Cytochem. 1981 Apr;29(4):577-80. doi: 10.1177/29.4.6166661.
8
Monoclonal antibodies (MT1, MT2, MB1, MB2, MB3) reactive with leukocyte subsets in paraffin-embedded tissue sections.与石蜡包埋组织切片中的白细胞亚群发生反应的单克隆抗体(MT1、MT2、MB1、MB2、MB3)
Am J Pathol. 1987 Jun;127(3):418-29.
9
Reshaping human antibodies for therapy.重塑用于治疗的人源抗体。
Nature. 1988 Mar 24;332(6162):323-7. doi: 10.1038/332323a0.
10
Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody CAMPATH-1H.重塑型人单克隆抗体CAMPATH-1H用于非霍奇金淋巴瘤的缓解诱导
Lancet. 1988 Dec 17;2(8625):1394-9. doi: 10.1016/s0140-6736(88)90588-0.